Top Growth Trends in the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market: Insights into Market Size and Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theIn Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The in vitro diagnostic (IVD) in cardiology and neurology market is set to expand, fueled by the growth of personalized medicine. This type of medicine customizes medical decisions, procedures, interventions, and treatments specific to each patient’s unique characteristics. The expansion of personalized medicine can be attributed to advancements in genomics, enhanced understanding of disease mechanisms, patient demand for customized treatments, and regulatory support, among other things. Personalized healthcare is facilitated by in vitro diagnostic (IVD) tests in cardiology and neurology, which provide essential information about a person’s genetic composition and health condition, thereby guiding personalized treatment strategies for heightened efficacy and reduced dangers. For example, the Personalized Medicine Coalition, a professional membership organization based in the US, reported in 2022, that the approval of 12 new personalized medicines made up roughly 34% of all newly approved therapies, marking a significant increase from prior years. Consequently, the rising number of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) in cardiology and neurology market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
#How Will the CAGR of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Influence Its Overall Growth by 2034?
There has been significant growth in the size of the in vitro diagnostic (IVD) market for cardiology and neurology in recent years. The market, which was valued at $15.84 billion in 2024, is projected to reach $17.27 billion in 2025 with a compound annual growth rate (CAGR) of 9.0%. This historic growth can be tied to factors such as an increase in age-related cardiovascular and neurological disorders, a rising aging population, a growing focus on preventive healthcare and early detection of diseases, an escalating burden of cardiovascular diseases (CVDs) and neurological disorders like stroke and Alzheimer’s disease, an increase in healthcare infrastructure investment, and a supportive regulatory framework that oversees the approval and reimbursement of diagnostic tests.
The market for in vitro diagnostic (IVD) in the disciplines of cardiology and neurology is projected to experience robust growth in the coming years, reaching a worth of $24.07 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. This anticipated growth over the forecast period can be linked to various factors including the move towards personalized medicine in both fields, an increased desire for quick and localized testing solutions, the broadening of telemedicine and remote consultation services, and a surge in research efforts. Key trends for the forecast period involve the emergence of liquid biopsy technologies, progress in nanotechnology, the adoption of remote monitoring devices like implantable cardiac monitors and brain-computer interfaces, the application of multiplex biomarker panels, breakthroughs in medical imaging methods such as MRI, CT, and PET scans, as well as the creation of companion diagnostics for cardiovascular and neurological medications.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15829
What Are the Current Market Growth and Trends in theIn Vitro Diagnostic (IVD) In Cardiology And Neurology Market That Industry Players Should Watch?
Leading enterprises in the cardiology and neurology (IVD) in vitro diagnostic market are constructing artificial intelligence(AI)-worked incorporated epigenetic frameworks for early disease recognition and risk evaluation. These AI-based engines employ machine-learning models and superior biomarker review methods to enhance precision and sensitivity in diagnosis and supervision of cardiovascular diseases, thus confronting major disease progression factors. For example, Cardio Diagnostics Holdings Inc., a biotech firm from the US, introduced PrecisionCHD in February 2023. It’s an AI-powered blood test designed for the early detection of coronary heart disease (CHD). With the assistance of the organization’s consolidated epigenetic-genetic engine, this test intends to detect and avert the most frequent form of cardiovascular disease. PrecisionCHD merges epigenetic and genetic biomarkers with machine-learning algorithms, administering over 75% sensitivity in both genders. It associates a patient’s biomarker profile to changeable risk factors, which are substantial contributors to CHD, such as smoking, diabetes, high blood pressure, and elevated cholesterol levels. As a non-invasive alternative to exercise stress trials or angiograms, PrecisionCHD permits the collection of blood samples in-office or at a patient’s residence.
What Are the Major Market Players Making an Impact on theIn Vitro Diagnostic (IVD) In Cardiology And Neurology Market Growth?
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Driving Opportunities and Innovations?
The in vitro diagnostic (IVD) in cardiology and neurology market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Technology: Immunoassays, Molecular Diagnostics, Hematology, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers, Point-Of-Care Devices, Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents, Test Kits, Assay Consumables
3) By Software And Services: Diagnostic Software, Data Management Software, IVD Consulting And Support Services
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theIn Vitro Diagnostic (IVD) In Cardiology And Neurology Market?# Market Expansion?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market 2025, By The Business Research Company:
Medical Image Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-image-management-global-market-report
Image Guided Surgery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/image-guided-surgery-devices-global-market-report
Artificial Intelligence (AI) Image Recognition Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
